Beckman Coulter Diagnostics has made available Issue 4 of its DxN VERIS Molecular Diagnostics Evidence Pack. Following presentation of eight new scientific posters at the European Societyfor Clinical Virology meeting in Edinburgh, the Evidence Pack has been updated and now contains more than 20 evaluation posters presented at key infectious disease meetings across Europe.
“These independent evaluations of the DxN VERIS Molecular Diagnostics System and assays will be of great interest to virology laboratories,” said Richard Creager (Beckman Coulter Diagnostics).“The findings underpin theworkflow advantages that DxN VERIS can bring to the modern laboratory, dramatically reducing hands-on time to first result for HIV-1, HCV, HBV and CMV viral loads.”
As stated by a UK evaluation site at a recent seminar held at EuroMedLab in Paris, DxN VERIS is simple to use withroutine operator training taking approximately 20 minutes from start to fullsystem operation.DxN VERIS has all necessary consumables and reagents onboard, so tests can be up and running in less than 10 minutes.
Great savings can be made in manpower and hands-on time as extraction, amplification and detection are all undertaken in the one system.DxN VERISalso provides true single-sample randomaccess, allowing multiple assays andsamples to be run at the same time, enabling laboratories to go from sample tofirst result in as little as 70 minutes.
Fully CE-marked, the system currently has assays for HIV-1, HCV,HBV and CMV, with many other assays currently in development.Assaysare supplied in a single cartridge system sothere are no empty wells, which reduces wastage andconsumable costs.
www.beckmancoulter.com